Portfolio POC

How CRT's Pioneer Fund got its first win by selling a Phase I asset to ProNAi

Cancer Research Technology Ltd.'s push to move molecules into the clinic rather than out-license them at very early stages of development has paid its first dividends. Late last month, the Cancer Research Technology Pioneer Fund sold a Phase

Read the full 389 word article

How to gain access

Continue reading with a
two-week free trial.